Health Catalyst, Inc. (HCAT): Submission of Matters to a Vote of Security Holders
Health Catalyst, Inc. (HCAT) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. hcat-20260716 FALSE 0001636422 0001636422 2026-07-16 2026-07-16 0001636422 dei:FormerAddressMember 2026-07-16 2026-07-16 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________ FORM 8-K ____________________
How this was made
The 30-second read
Why it matters
The disclosure confirms which directors were elected and whether specific governance and advisory proposals passed, including ratification of Ernst & Young LLP and rejection of a classified board phase-out.
Market read
This is a routine governance vote tally with one notable outcome: stockholders did not approve the classified board structure phase-out restatement proposal.
What to watch
Traders may be watching for any subsequent proxy-related litigation, board reconstitution details, or follow-on corporate governance steps, none of which are disclosed here.
Background
Health Catalyst, Inc. reported final results from its July 16, 2026 annual stockholders meeting via SEC Form 8-K, Item 5.07.
Ticker impact
HCAT filed an 8-K reporting final shareholder vote results on four proposals, including director elections and a failed charter restatement.
Low likelihood of a sustained price move solely from this vote tally; any reaction would be limited and short-lived.
The 8-K provides voting counts for board/director and governance proposals, with no new financial guidance, transactions, or regulatory actions disclosed.
Market effects
Minimal. Governance vote outcomes do not materially change healthcare IT sector fundamentals based on the provided text.
Minimal. No regional macro or cross-border transaction details are included.
Minimal. The disclosure is company-specific and does not reference global regulatory or commercial developments.
Counterpoint
The failed proposal to phase out the classified board structure could matter for longer-term governance and takeover dynamics, but the article provides no additional context or follow-on actions.
Key entities
- issuerHealth Catalyst, Inc.
Nasdaq-listed company filing the 8-K with final shareholder vote results on four annual meeting proposals.
- auditorErnst & Young LLP
Independent registered public accounting firm ratified by stockholders for the fiscal year ending December 31, 2026.
- director_nomineeJustin Spencer
Elected as Class I director with votes for and withheld counts reported in the filing.
- director_nomineeMathew Arens
Elected as Class I director with votes for and withheld counts reported in the filing.
